Literature DB >> 28447004

Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs. 3-field).

Philippe Nafteux1, Lieven Depypere1, Hans Van Veer1, Willy Coosemans1, Toni Lerut1.   

Abstract

Surgery for esophageal carcinoma and carcinoma of the gastro-esophageal junction (GEJ) is considered as one of the most complex and challenging interventions on the digestive tract. This is due to the intimate relations with vital structures in the chest and the tendency of early lymphatic dissemination via a dense and complex submucosal network. This review article discusses the different aspects of surgical access routes in the light of the ever-evolving techniques, in particular the minimally invasive esophagectomy (MIE). The aspects of surgical approach are inextricably linked to the still ongoing debate on extent of lymphadenectomy, a debate that is obtaining a new dimension in view of the widely applied neoadjuvant therapy protocols as well as in view of the increasing importance of quality of life aspects after surgery. Finally, the authors provide a practical and patient tailored approach as applied in their center.

Entities:  

Keywords:  Esophageal cancer; lymph node dissection; minimally invasive esophagectomy (MIE); transhiatal; transthoracic

Year:  2017        PMID: 28447004      PMCID: PMC5387152          DOI: 10.21037/acs.2017.03.04

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  43 in total

1.  Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan.

Authors:  H Watanabe; H Kato; Y Tachimori
Journal:  Recent Results Cancer Res       Date:  2000

2.  Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer.

Authors:  A R Davies; H Sandhu; A Pillai; P Sinha; F Mattsson; M J Forshaw; J A Gossage; J Lagergren; W H Allum; R C Mason
Journal:  Br J Surg       Date:  2014-02-24       Impact factor: 6.939

3.  Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.

Authors:  Marcus Feith; Hubert J Stein; J Rüdiger Siewert
Journal:  Surg Oncol Clin N Am       Date:  2006-10       Impact factor: 3.495

4.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

5.  Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.

Authors:  A Koen Talsma; Joel Shapiro; Caspar W N Looman; Pieter van Hagen; Ewout W Steyerberg; Ate van der Gaast; Mark I van Berge Henegouwen; Bas P L Wijnhoven; J Jan B van Lanschot; Maarten C C M Hulshof; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W ten Kate; Geert-Jan Creemers; Cornelis J A Punt; John T M Plukker; Henk M W Verheul; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

6.  Extended radical esophagectomy for superficially invasive carcinoma of the esophagus.

Authors:  T Nishimaki; T Suzuki; T Kanda; I Obinata; S Komukai; K Hatakeyama
Journal:  Surgery       Date:  1999-02       Impact factor: 3.982

7.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

8.  Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.

Authors:  Jesper Lagergren; Fredrik Mattsson; Janine Zylstra; Fuju Chang; James Gossage; Robert Mason; Pernilla Lagergren; Andrew Davies
Journal:  JAMA Surg       Date:  2016-01       Impact factor: 14.766

9.  Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis.

Authors:  Kamal Nagpal; Kamran Ahmed; Amit Vats; Danny Yakoub; David James; Hutan Ashrafian; Ara Darzi; Krishna Moorthy; Thanos Athanasiou
Journal:  Surg Endosc       Date:  2010-01-28       Impact factor: 4.584

10.  Optimum lymphadenectomy for esophageal cancer.

Authors:  Nabil P Rizk; Hemant Ishwaran; Thomas W Rice; Long-Qi Chen; Paul H Schipper; Kenneth A Kesler; Simon Law; Toni E M R Lerut; Carolyn E Reed; Jarmo A Salo; Walter J Scott; Wayne L Hofstetter; Thomas J Watson; Mark S Allen; Valerie W Rusch; Eugene H Blackstone
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

View more
  5 in total

1.  Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.

Authors:  Noriyuki Hirahara; Takeshi Matsubara; Shunsuke Kaji; Hikota Hayashi; Koki Kawakami; Yohei Sasaki; Satoshi Takao; Natsuko Takao; Ryoji Hyakudomi; Tetsu Yamamoto; Yoshitsugu Tajima
Journal:  BMC Cancer       Date:  2022-06-30       Impact factor: 4.638

2.  Effect of perioperative oral care on prevention of postoperative pneumonia associated with esophageal cancer surgery: A multicenter case-control study with propensity score matching analysis.

Authors:  Sakiko Soutome; Souichi Yanamoto; Madoka Funahara; Takumi Hasegawa; Takahide Komori; Shin-Ichi Yamada; Hiroshi Kurita; Chika Yamauchi; Yasuyuki Shibuya; Yuka Kojima; Hirokazu Nakahara; Takahiko Oho; Masahiro Umeda
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

3.  ANXA10 induction by interaction with tumor-associated macrophages promotes the growth of esophageal squamous cell carcinoma.

Authors:  Himiko Kodaira; Yu-Ichiro Koma; Masayoshi Hosono; Nobuhide Higashino; Kazuki Suemune; Mari Nishio; Manabu Shigeoka; Hiroshi Yokozaki
Journal:  Pathol Int       Date:  2019-02-13       Impact factor: 2.534

4.  Machine learning models predict lymph node metastasis in patients with stage T1-T2 esophageal squamous cell carcinoma.

Authors:  Dong-Lin Li; Lin Zhang; Hao-Ji Yan; Yin-Bin Zheng; Xiao-Guang Guo; Sheng-Jie Tang; Hai-Yang Hu; Hang Yan; Chao Qin; Jun Zhang; Hai-Yang Guo; Hai-Ning Zhou; Dong Tian
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

5.  ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up?

Authors:  Lieven Peter Depypere; Gil Vervloet; Toni Lerut; Johnny Moons; Gert De Hertogh; Xavier Sagaert; Willy Coosemans; Hans Van Veer; Philippe Robert Nafteux
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.